Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,37 USD | +3,79% | +11,20% | +18,80% |
16/04 | Clearside Biomedical, Inc benoemt Anthony S. Gibney tot lid van de Raad van Bestuur | CI |
18/03 | Clearside Biomedical benoemt Victor Chong tot medisch directeur | MT |
Omzet 2024 * | 2,74 mln. 2,57 mln. | Omzet 2025 * | 7,36 mln. 6,9 mln. | Marktkapitalisatie | 98,63 mln. 92,44 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -39 mln. -36,55 mln. | Nettowinst (verlies) 2025 * | -43 mln. -40,3 mln. | EV/omzet 2024 * | 28,2 x |
Nettoliquiditeiten 2024 * | 21,26 mln. 19,93 mln. | Nettoschuld 2025 * | 12,33 mln. 11,55 mln. | EV/omzet 2025 * | 15,1 x |
K/w-verhouding 2024 * |
-2,51
x | K/w-verhouding 2025 * |
-2,28
x | Werknemers | 30 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,84% |
Recentste transcriptie over Clearside Biomedical, Inc.
1 dag | +3,79% | ||
1 week | +11,20% | ||
Lopende maand | -9,15% | ||
1 maand | -14,72% | ||
3 maanden | +7,75% | ||
6 maanden | +73,75% | ||
Lopend jaar | +18,80% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 08-08-17 |
Charles Deignan
DFI | Director of Finance/CFO | 59 | 01-01-12 |
Susan L. Coultas
CTO | Chief Tech/Sci/R&D Officer | - | 14-06-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
George Lasezkay
CEO | Chief Executive Officer | 72 | 08-08-17 |
Jeffrey Edwards
BRD | Director/Board Member | 64 | 26-09-18 |
Christy Shaffer
BRD | Director/Board Member | 66 | 01-01-12 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 1,36 | +3,03% | 114 345 |
18-04-24 | 1,32 | +4,76% | 331 169 |
17-04-24 | 1,26 | +9,57% | 329 284 |
16-04-24 | 1,15 | -10,85% | 332 218 |
15-04-24 | 1,29 | +3,20% | 184 316 |
uitgestelde koers Nasdaq, 19 april 2024 om 16:57 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,80% | 98,63 mln. | |
-2,83% | 102 mld. | |
+1,93% | 96,07 mld. | |
-1,57% | 21,66 mld. | |
-17,49% | 20,77 mld. | |
-6,87% | 18,53 mld. | |
-40,31% | 16,91 mld. | |
-27,68% | 13,79 mld. | |
+0,47% | 13,33 mld. | |
+21,12% | 10,94 mld. |